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Irreversible lethal electroporation (IRE) is a new non-thermal ablation modality that uses 
short pulses of high amplitude static electric fields (up 1000 V/cm) to create irreversible pores 
in the cell membrane, thus, causing cell death. Recently, IRE has emerged as a promis-
ing clinical modality for cancer disease treatment. Here, we investigated the responses of 
tumour human HeLa cells when subjected to IRE in the presence of BNNTs. These consist 
of tiny tubes of B and N atoms (arranged in hexagons) with diameters ranging from a 1 to 
3 nanometres and lengths ,2 mm. BNNTs have attracted wide attention because of their 
unique electrical properties. We speculate that BNNTs, when interacting with cells exposed 
to static electrical fields, amplify locally the electric field, leading to cell death. In this work, 
electroporation assays were performed with a commercial electroporator using the cell- 
specific protocol suggested by the supplier (exponential decay wave, time constant 20 ms) 
with the specific aim to compare IRE in absence and in presence of BNNTs. We observed 
that BNNTs have the capacity to decrease substantially the voltage required for IRE. When 
cells were pulsed at 800 V/cm, we observed a 2,2-fold reduction in cell survival in the pres-
ence of BNNTs compared to controls. We conclude that the death of the tumour cells 
exposed to IRE is strongly enhanced in the presence of BNNTs, indicating their potential 
therapeutic application.
Key words: Boron nitride nanotubes; Irreversible electroporation.
Introduction
In-situ ablation of diseased tissues, most commonly of neoplastic tissues, has 
become an important minimally invasive treatment alternative to surgical resec-
tion. Most methods for in-situ ablation are based on thermal techniques using rapid 
freezing below 240º C as with cryosurgery (1) or heat, e.g., radiofrequency (2) 
and high-intensity focused ultrasound (3) or nanoparticle-mediated irradiation (4). 
Irreversible (lethal) electroporation (IRE) has been proposed as an alternative 
non-thermal technique for minimally invasive in-situ ablation based on the use 
of electrical pulses. When an electric field is applied to a cell, a change in trans- 
membrane potential is induced, which can cause biochemical and physiological 
changes of the cell. When the threshold value of the trans-membrane potential is 
exceeded, the cell membrane becomes permeable, thus allowing entrance of mol-
ecules that otherwise cannot cross the membrane (5). A further increase in the 
electric field intensity may cause irreversible membrane permeabilization when 
these pulses create extensive defects (pores) in the cell membrane lipid bilayer 
such that the integrity of the cell membrane cannot be restored (irreversible 
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electroporation). This leads to cell death by apoptosis through 
loss of cell homeostasis (6). Irreversible electroporation is thus 
capable of efficient in-situ ablation targeted to the tumour site. 
A study by Davalos et al. showed that IRE can ablate sub-
stantial volumes of tissue without inducing a thermal effect, 
thereby providing a novel tissue ablation modality and has 
opened the way for the use of IRE in clinical practice (7). 
The promising results of this study were subsequently con-
firmed by other reports involving in-vitro studies on cells (8), 
in-vivo small animal models (9) and in large animal models 
of IRE targeted to the liver (10) and the heart (11). The most 
important finding reported by these studies is that irreversible 
electroporation produces precisely delineated ablation zones 
with cell scale resolution between ablated and non-ablated 
areas, without any intermediate zone of partial damage as is 
encountered with thermal ablation. Furthermore, these reports 
have demonstrated that irreversible electroporation affects 
only the membrane of living cells and spares the supporting 
stromal tissues. Rubinsky et al. (10) were the first to highlight 
the beneficial clinical features of IRE, including avoidance of 
collateral damage to large blood vessels and bile ducts, rapid 
tissue regeneration (attributed to the retained integrity of large 
blood vessels scaffolds), rapid activation of the immune sys-
tem, minimal fibrosis and the potential ability to treat tumours 
adjacent to large blood vessels by avoiding the heat sink effect 
of circulating blood (12).
Despite the potential and advantages of the technique for 
clinical in-situ ablation, to date, IRE has been limited by 
the need of strong electrical fields of the order of 1000-
1500 V/cm (8, 9). In particular, there are justifiable concerns 
regarding possible adverse effects of strong electric fields 
created by IRE ablation on other non-targeted tissues, e.g., 
muscle contractions, cardiac arrhythmias which may occur 
especially during the “vulnerable” period of the cardiac 
cycle, i.e., atrial or ventricular systole (13, 11). Currently, all 
clinical IRE ablation units utilize cardiac synchronization to 
ensure patient safety (14). Another clinical limitation con-
cerns the pain induced by the electrical field itself or by the 
implanted electrodes for energy delivery, which requires that 
IRE is performed under general anaesthesia. Additionally, 
work has be done to address the limitation of muscle con-
tractions induced by conventional electroporation and IRE. 
Daskalov et al. have used biphasic pulses to reduce patient 
discomfort during electrochemotherapy (15) and Arena et al. 
have used high-frequency bipolar bursts to eliminate muscle 
contractions during non-thermal IRE (16).
The present study is the first report of an attempt to reduce 
the magnitude of the electric field required for IRE in order to 
overcome its current limitations. Specifically, the study con-
cerns the use of IRE mediated by nanomaterials with tailored 
properties, exemplified by boron nitride nanotubes (BNNT). 
BNNTs represent an important class of non-carbon inorganic 
nanotubes. Structurally, BNNT is similar to a carbon nanotube 
(CNT). However, electronically, BNNT is quite different from 
its carbon analogue. Normally, BNNTs are insulating, possess 
excellent mechanical properties, and are much more thermally 
and chemically stable compared to CNTs (17). Nevertheless, 
to date BNNTs have attracted much less attention than CNTs, 
due to the difficulties in their synthesis. Although currently the 
biological behaviour of BNNTs remains largely unexplored 
(18, 19), various biomedical applications have been recently 
suggested (20, 21) and initial attempts to explore their potential 
have been reported (22, 23). Our group was the first to report 
on the interactions of polymer coated singly dispersed BNNTs 
with living cells, demonstrating their cytocompatibility (20). 
Lahiri et al. studied the interactions of the osteoblasts and mac-
rophages with bare BNNTs and reported their non-cytotoxicity 
(24). Subsequently, these findings were confirmed by other 
reports (18, 25). Recently, Horvath and colleagues tested the 
cytocompatibility of BNNTs on cells from the lung since they 
were interested in human exposure through inhalation (19). 
Both pulmonary epithelial cells and resident macrophages 
exhibited toxic effects when exposed to BNNTs in a dose and 
time-dependent manner. However, the toxicity of BNNTs for 
HEK cells observed in this study contradicts the findings of the 
study by Chen et al. who reported that HEK and CHO cells are 
not affected by the presence of BNNTs in the culture medium 
up to a dose of 100 mg/ml (25). This apparent controversy 
arises from the different length of the nanotubes employed 
in the different studies. BNNTs used by Horvath et al. were 
longer (.10 mm) than those used by Ciofani et al. (,2 mm) 
(18, 20) and Chen et al. (,6 mm) (25). Evidently, length is a 
crucial parameter for the cytotoxicity of the nanofibers. It has 
been clearly demonstrated for the structurally analogue CNTs, 
that nanotube lengths .10 mm induce the formation of granu-
lomas similar to those caused by asbestos fibres following 
intraperitoneal implantation in mice. This pathology is attrib-
uted to ‘frustrated phagocytosis’ by macrophage cells unable 
to endocytose the long tubes with the subsequent formation of 
giant cells by fusion of single cells (26).
All together, the preliminary data available in literature seem 
to confirm the potential of BNNTs in the biomedical field, 
provided due attention is paid to the parameters influencing 
the toxicity of nanomaterials (i.e., morphology, methods of 
production, impurities, etc.).
In a previous study, we described that BNNTs can be used 
as nanotools to enable reversible cell permeabilization with 
low electric fields (27). In the present study, we compare 
BNNT-mediated IRE with conventional IRE using a com-
mercial electroporator. The results demonstrate that BNNTs 
allow a substantial reduction of the electric field required for 
irreversible electroporation of human HeLa cell line.
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Materials and Methods
BNNT Production and Characterization
The BNNTs used in the study were synthesized via the 
pressurized vapour/condenser (PVC) method (28). BNNTs 
manufactured by this technique have been reported to have 
a unique morphology, namely high crystallinity, very high 
aspect ratio, high mechanical flexibility, and very small diam-
eter, consisting of one to a few walls. The morphology of 
the BNNTs was determined by high-resolution transmission 
electron microscopy (TEM). Images were taken at 100 kV on 
a JEOL JEM-2100 F electron microscope.
In the present study, an aqueous dispersion of BNNTs was 
realized with glycol-chitosan (Sigma, St. Louis, MO, U.S.A.). 
Glycol-chitosan was dissolved in Phosphate Buffer Solution 
(PBS, Lonza, Milan, Italy) at a concentration of 0.1% (w/v), 
after which 1 mg/ml of BNNTs was added. The resulting mixture 
was sonicated with a sonicator (Bransonic2510, CT, USA) at 
20 W for 16 h. Spectrophotometric analysis was performed with 
a LIBRA S12 Spectrophotometer UV/Vis/NIR (Biochrom).
Cell Cultures
Human epithelial carcinoma cell line (HeLa) was obtained 
from American Type Culture Collection (ATCC, Rockville, 
MD). HeLa cells were grown in a complete culture medium 
consisting of DMEM supplemented with 2 mM Lglutamine, 
100 IU/ml penicillin, 100 mg/ml streptomycin and 10% heat 
inactivated calf serum (ECS0040L, EuroClone, Italy). Cells 
were maintained at 37°C in a saturated humidity atmosphere 
of 95% air and 5% CO2.
Electroporation Assays
Electroporation assays were performed with a commercial elec-
troporator (Gene Pulser Xcell, Biorad). The protocol for cell 
permeabilization was as follows: cells were trypsinized, centri-
fuged for 5 min at 350 g and re-suspended in pulsing medium at 
a concentration of 106 cells/ml. Cells were electroporated using 
an exponential decay wave, a 2-mm cuvette and a volume of cell 
suspension of 100 ml, according to the protocol provided by the 
supplier. The voltage suggested by the supplier for reversible 
electroporation was 160 V (corresponding to an electric field of 
800 V/cm). The range of voltage tested in the present work was 
0-220 V (corresponding to an electric field of 0-1100 V/cm). In 
all experiments, the time constant was 20 6 3 ms.
Three experimental groups were used in the study:
1. Sample. The pulsing medium was Opti-MEM added with 
polymer: BNNT (polymer and nanotube concentrations 
were 1.25 mg/ml).
2. Control 1. The pulsing medium used was Opti-MEM 
added with polymer (concentration of 1.25 mg/ml).
3. Control 2. The pulsing medium used was Opti-MEM.
After electroporation, cell suspension was diluted 1:5 in fresh 
cell culture medium. 100 ml of this suspension was seeded 
in each well of a 96-well plate to assess cell viability. Cell 
viability was assessed after 24 h of incubation.
Cell Viability
3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bro-
mide, (MTT, Sigma, St. Louis, MO, U.S.A.) cell prolifera-
tion assay was used to assess cell viability. For MTT assay 
20 3 103 cells were seeded into each well of a 96-well plate 
and then incubated with the culture medium. This was then 
replaced with 100 ml of medium containing 0.5 mg/ml of 
MTT and cells were incubated for 2.5 h at 37°C, 5% CO2. In 
this assay, the mitochondrial dehydrogenase of viable cells 
reduces the water-soluble MTT to water-insoluble formazan 
crystals. The MTT-containing medium was then replaced with 
100 ml of dimethylsulfoxide (DMSO, Sigma St. Louis, MO, 
U.S.A.) and left for 5 min on a platform shaker to solubilize 
the converted formazan. The absorbance was measured on a 
Versamax microplate reader (Molecular Devices, Sunnyvale, 
CA, U.S.A.) at a wavelength of 570 nm with background sub-
tracted at 690 nm. All data are normalized with respect to the 
negative control (cells incubated with normal medium).
Cell counting assay was performed with ScepterTM cytometer 
(Merck Millipore, Milan, Italy).
Statistical Analysis
At least 12 replicates were used for each experiment. Val-
ues are expressed as means 6 standard error of the mean 
(S.E.M.). Statistical significance was assessed by one way 
analysis of variance (ANOVA) followed by post-hoc com-
parison test (Tukey). Significance was set at 5%.
Results
We initially tested the fabricated BNNTs by TEM. A typi-
cal isolated, as-grown, PVC-synthesized BNNT is shown in 
Figure 1. Such BNNTs are highly crystalline, have one or just a 
few walls and, and the tube walls have few defects and are paral-
lel to the axis. These BNNTs are highly flexible, as can be seen 
by the close conformation of the tube in Figure 1 to the carbon 
support grid, presumably by electrostatic forces. No catalysts 
are used to produce PVC-grown BNNTs, so the raw material 
contains only boron and BN. There are impurities, namely BN 
flakes and rods on the 100 nm to 1 micron size range (similar 
in scale to ball-mill-grown BNNTs) and some solidified, nano-
scale boron droplets. The BNNTs themselves have typically 
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1 to 5 walls, 2 and 3 wall tubes being the most common. These 
tubes have diameters ranging from about 2.5 to 5 nm. 
As-produced nanotubes are up to millimeters in length (28). 
This extraordinary length gives the raw material the appear-
ance of conventional textile fibres. These macroscopic bun-
dles are broken up efficiently by the sonication procedure. 
Sonication causes rupture of hydrophobic and Van der Waals 
forces between BNNTs and breaks the tubes at the defect 
sites. The presence of the surfactant (glycol-chitosan) has the 
effect of stabilizing the tubes in aqueous solution and hence 
dispersion. The resulting mixture contains nanotubes singly 
dispersed (or as aggregates of few tubes) with an average 
length of 1 6 0.5 mm. UV-sis analysis of the dispersion con-
firmed the characteristic peak of BNNTs (Figure 2) (22).
Prior to validation of their biological use, BNNTs were tested 
for their biocompatibility by cell viability assays using aque-
ous dispersions of glycol-chitosan (GC: BNNT) at a nanotube/
polymer mass ratio of 1:1. Specifically, dose response assays 
were performed in order to assess the ED25, i.e., the nano-
tube dose reducing cell viability of 25%. GC: BNNTs and GC 
were tested in the range 10 ng/ml – 1 mg/ml. GC was found not 
to induce cytotoxicity at any tested concentration (data not 
showed). Experimental results showed that the cytotoxicity 
induced by the nanotubes is dose-dependent (Figure 3). ED25 
was observed at about 253 ng/ml of BNNTs (R2 5 0.9971). 
Based on these experimental data, further experiments involv-
ing cells involved incubation with a BNNTs concentration of 
250 ng/ml in the culture medium.
The next stage of the study involved the performance of stan-
dard IRE against BNNT-mediated IRE. HeLa cells were sub-
jected to electroporation in GC: BNNT modified Opti-MEM 
or GC modified Opti-MEM or pure Opti-MEM. Electropo-
rated cells were diluted in normal cell growth medium (dilu-
tion ratio 1:5) and incubated for 24 h before to assess cell 
viability. Figure 4 shows viability of cells electroporated in 
presence of GC: BNNT or GC as a function of the applied 
electrical fields. Viabilities of cell electroporated in GC mod-
ified Opti-MEM or pure Opti-MEM were not statistically dif-
ferent (data not showed). Cells electroporated in GC: BNNT 
modified Opti-MEM was subjected to cytometric analysis. 
The results revealed that the increment of the applied electric 
field causes a decrease of cell density and a corresponding 
increase of cellular debris (Figure 5).
Discussion and Conclusion
BNNTs used in the study were produced by a pressurized 
vapour/condenser (PVC) method described by the authors in 
a previous report (28). This method produces, without cata-
lysts, highly crystalline, very long, small-diameter BNNTs. 
The uniformity, small diameter (,5 nm), and high flexibility 
of the nanotube are clearly evident by the ready deforma-
tion and adhesion of the molecule to the microscope support 
grid (Figure 1). This flexibility demonstrates that these high 
aspect ratio BNNTs are able to conform to cellular-scale 
structures with minimal applied mechanical force, which 
may greatly reduce their cytotoxic response. An important 
advantage of the morphology of PVC-grown BNNTs may be 
thus improved baseline cytotoxicity. Work by Horváth et al. 
(19) on the inherent toxicity of BNNTs on epithelial cells, 








































Figure 3: Dose response curve. Cells incubated 24 hours at various con-
centrations of polymer coated nanotubes. Cell viability expressed as percent-
age of the control (cells treated with polymer alone). N 5 12. p* , 0.0001.
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alveolar macrophages, fibroblast cells, and human embryonic 
kidney cells, reported that the toxicity is highly morphology 
dependent. In particular, mechanically stiff BNNTs, in their 
case up to 80 nm in diameter and up to 10 microns in length, 
were found to be more toxic than relatively flexible (20 nm 
diameter) carbon nanotubes. PVC-Grown BNNTs, at less 
than 5 nm diameter, appear to be much more flexible still, and 
may prove to be proportionally less toxic, completely avoid-
ing the ‘rod-like’ disruption of cell membranes observed by 
Horvath. Other important factors affecting toxicity to cells 
and tissues by BNNTs include water solubility, length and 
purity. As-produced nanotubes have reduced solubility in 
aqueous solution, which is essential for biological interac-
tions and biocompatibility. Length is a crucial factor as one 
important study (26) has demonstrated that carbon nanotubes 
with length .10-15 mm induce the formation of granulomas 
similar to those caused by asbestos fibres. These problems 
can be easily solved by dispersing the nanotubes in a polymer 
solution with the aid of sonication. This produces water dis-
persions of short nanotubes (1 6 0.5 mm) with a non-covalent 
polymer coating. BNNTs produced in the present work 
revealed a dose-dependent cytotoxicity (possibly related 
to the presence of impurity). This was carefully taken into 
account in the present study as all biological assays were per-
formed at dose below to ED25.
Another important advantage of the morphology of PVC-
grown BNNTs in the present study is the high aspect ratio, 
which renders the tubes very efficient energy nano-transducers. 
As previously discussed in a previous report (27), the mecha-
nism of BNNT mediated electroporation is related to the 
dielectric response of BNNTs to static electric fields.
The process of cell electroporation is explained by the 
Neumann theory (29). Briefly, with static fields or low fre-
quency alternating fields, the potential distribution in the 
region surrounding a spherical cell with a non-conductive 
membrane is described by the Laplace equation with appro-








where Djm is the trans-membrane voltage, E
out
 is the external 
electric field, a is cell radius and g the polar angle between 
E
out
 and the site on the cell membrane where Djm is mea-
sured. According to the classical definition of electric field 
strength as the negative electric potential gradient, the mem-
brane field strength is given by
Em 5 Djm / d
where d is the membrane thickness. At the poles (g 5 0, p), 
the trans-membrane electric field Em is large compared with 







out  , corresponding to a 1500 fold 
amplification of the external electric field (for a cell with 
a 5 5 mm and d 5 5 nm).
By analysing the response of a dielectric nanotube (diameter 
D, length l, density r, transverse and longitudinal dielectric 
constants e^, eII), the screening factor in the vacuum, defined 
as the ratio between the external electric field Eout and the 
electric field within the nanotube ENT, is given by (30)






This means that a nanotube exposed to an external electric 
field Eout amplifies the field in proximity of its surface by a 
factor b2 5 e*.
The value of b2 depends from many factors, included the 
dielectric constants of the nanotube and the aspect ratio. 





















Figure 4: HeLa cells treated with polymer coated nanotubes (CG:BNNT) 
and polymer alone (CG): cell viability after 24 hours of incubation following 
electroporation assay. Cell viability expressed as percentage of the control 
(cells not electroporated). N 5 14.
Figure 5: Cytometer analysis.
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By decreasing the aspect ratio, b2 approaches 1. In order to 
enhance b2, the aspect ratio should be maximised. As already 
mentioned, the average length of the nanotubes must be 
below 2 mm in order to address cytocompatibility issues. Thus 
the small diameter nanotubes of this study are eminently suit-
able for the proposed application. Another feature that makes 
our BNNTs excellent candidates is their superior dielectric 
properties. BNNTs, whether single-walled or multi-walled, or 
packed in bundles, are excellent semiconductors, with a large 
band gap that is largely independent of the tube diameter, chi-
rality, and number of walls (31, 32). In contrast, carbon nano-
tubes exhibit a polarizability tensor highly anisotropic because 
of their inherent anisotropy (33). Specifically, polarizability 
for external fields in the longitudinal direction is considerably 
larger than that in the radial direction. The longitudinal polar-
izability of SWCNTs scales as the inverse square of the band 
gap, which depends on the chiral vector i.e., the armchairs 
SWCNTs are metals while zigzags SWCNTs are semicon-
ductors. In MWCNTs the overall longitudinal polarizability 
is given by the sum of the polarizabilities of the constituent 
tubes: a metallic behaviour can be thus assumed. The trans-
verse polarizability of SWCNTs is insensitive to band gaps 
and chirality and is proportional to the square of the effective 
radius. In MWCNTs the outer layers dominate the response. 
The consequence of this anisotropy is that the application 
of an external electric field generates a torque, which aligns 
the CNT along the field direction. In conclusion, although 
CNTs also possess the ability to amplify the external field, the 
application of two perpendicular fields as described in (34) is 
required for effective field amplification. This requires a dedi-
cate set-up, which is not compatible with commercial devices 
already available for biotechnology laboratories and clinics.
BNNTs by virtue of their superior properties compared to 
CNTs are able to overcome these limitations and are thus the 
preferred nanomaterial for IRE. Because of the polar nature of 
the B–N bond (35), BNNTs preferentially form zigzag (rather 
than armchair or chiral) structures. BNNTs thus exhibit stable 
electronic properties, with a uniform band gap of 5.5 eV (32). 
These properties make BNNTs the best nano-probes for enhanc-
ing the local electric field at the cell interface. Our experimen-
tal results confirmed that BNNTs constitute a very efficient 
tool for decreasing the energy requirement for irreversible elec-
troporation (Figure 4). The voltage suggested by the supplier 
for poration of HeLa cells (800 V/cm) was found to induce a 
cytotoxicity of 40% but this value rises to 88% in presence 
of the BNNTs. We can explain these experimental findings by 
the following considerations. When cells are placed in a BNNT 
modified medium, BNNTs interact with cell membrane due to 
the electrostatic forces. Previous analysis confirmed the inter-
action of BNNTs with mammalian cells and their subsequent 
internalization (18). As result of this interaction, the application 
of the electric field induces an amplification of the field in prox-
imity of the cell membrane of a factor b1b2, which explains the 
reduction of voltage required for IRE.
The mechanism through which the cell membrane is per-
meabilized by IRE is not yet fully understood. According 
to the electroporation theory, IRE should induce cell death 
by creating permanent nanopores in the cellular membrane 
using high voltage direct electrical current. These nanopores 
disrupt cell membrane. However, it is also reported that the 
permanent nanopores induced by IRE  in the cell membrane 
disrupt cellular homeostasis, which initiates apoptosis (36).
We found that BNNT mediated IRE induce complete disrup-
tion of the plasma membranes, cell swelling, and dilatation 
of cytoplasmic organelles. Our optical observations were 
confirmed by cytometer analysis (Figure 5). Experimental 
data showed that by increasing the electric field applied, 
cell density decreases. There is also a slight increase of the 
average cell diameter, which could be related to cell fusion 
phenomena naturally occurring during the electroporation 
process (37). Most importantly, the decrease of cell density is 
concomitant to a parallel increase of the peak at sizes ,8 mm, 
corresponding to the presence of cellular debris.
In conclusion, here, we evaluated first the dose of BNNTs, 
which does not affect significantly cell viability. Second, we 
compared BNNT mediated IRE with conventional IRE by using 
a commercial electroporator. We concluded that BNNTs allow 
a strong reduction of the electric field required for irreversible 
electroporation of human HeLa cells. Preliminary experimental 
data confirmed that the phenomenon of IRE could be further 
enhanced by increasing BNNT concentration in the medium 
(does-response behaviour, data not shown). In this regard, we 
are currently working on the purification and analysis of high 
purity nanotube. Further work will be devoted to investigate the 
translation of BNNT mediated IRE into cancer treatment. Many 
questions remain to be answered, such as how BNNTs will be 
delivered and distributed intratumorally, whether BNNTs can 
disperse through the tumor stroma to contact cell membranes, 
and if electric field enhancement can indeed reduce the required 
applied voltage for ablation as suggested. The challenge is to 
develop a clinical compliant protocol of enhanced IRE based on 
the use of high purity BNNTs with preclinical testing on in-vivo 
human tumour xenograft models in SCID mice.
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